NEW JERSEY - Tuesday, August 20th 2013 [ME NewsWire]
(BUSINESS WIRE)-- A clinical study to evaluate the prophylactic effect of non-invasive vagal nerve stimulation for the prevention of chronic migraine completed enrollment last week. The study, which is being sponsored by electroceutical healthcare company electroCore, involves 60 patients across six US sites1.
After an initial one month period, during which headache frequency data will be collected, the patients, all of whom experience migraine headaches on more than 15 daysper month, will be randomized into two groups. One group will use an active device and the other a sham device for a period of two months. All patients will then be provided with the active treatment device for a period of six months. Throughout the study, patients will record the number of headache days and the severity of the headaches experienced. The full results are expected in the second quarter of 2014.
This study, which is part of one
Read more »